Healthcare ETF Comparison: Fidelity's FHLC vs. Invesco's Biotech-Focused IBBQ

Healthcare ETF Comparison: Fidelity's FHLC vs. Invesco's Biotech-Focused IBBQ

Investors seeking exposure to the healthcare sector have two distinct options: the Fidelity MSCI Health Care Index ETF (FHLC) and the Invesco Nasdaq Biotechnology ETF (IBBQ). While both funds target the medical space, they differ significantly in their risk profiles, expense structures, and historical volatility, making the choice dependent on whether an investor seeks pure-play biotech or diversified healthcare.

Key Differences Between FHLC and IBBQ

The Fidelity MSCI Health Care Index ETF (FHLC) provides broad, low-cost access to the entire healthcare sector, whereas the Invesco Nasdaq Biotechnology ETF (IBBQ) targets a narrower slice of biotech with higher recent returns. The key differences between the two funds are outlined below:

• Expense Ratio: FHLC charges 0.08%, while IBBQ charges 0.19%.
• Share Price: As of 2026-08-27, FHLC's share price is $83.48, while IBBQ's share price is $36.45.
• 1-Year Return: FHLC's 1-year return is 29.2%, while IBBQ's 1-year return is 56.4%.
• Dividend Yield: FHLC offers a 1.2% dividend yield, while IBBQ offers a 0.7% dividend yield.
• Beta: Both funds have a beta of around 0.6, indicating similar price volatility relative to the S&P 500.

Investment Objectives and Risk Profiles

Investors seeking broad exposure to the healthcare sector may prefer the Fidelity MSCI Health Care Index ETF (FHLC), which holds over 300 securities and spans both biotech and the larger healthcare sector. This fund provides a more diversified portfolio with a lower max drawdown of 17.7% over the past five years.

On the other hand, investors comfortable with the volatility inherent in high-risk, high-reward biotech companies may prefer the Invesco Nasdaq Biotechnology ETF (IBBQ). This fund targets a narrower slice of biotech with higher recent returns, but its performance can be volatile due to unpredictable clinical trials data and federal approval processes.

Performance Comparison

The Fidelity MSCI Health Care Index ETF (FHLC) has a growth of $1,000 over five years (total return) of $1,331, while the Invesco Nasdaq Biotechnology ETF (IBBQ) has a growth of $1,000 over five years (total return) of $1,421. However, IBBQ's 1-year return is significantly higher at 56.4% compared to FHLC's 29.2%.

Conclusion

Investors seeking exposure to the healthcare sector have two distinct options: the Fidelity MSCI Health Care Index ETF (FHLC) and the Invesco Nasdaq Biotechnology ETF (IBBQ). The choice between these funds depends on an investor's investment objectives and risk tolerance. While FHLC provides broad, low-cost access to the entire healthcare sector, IBBQ targets a narrower slice of biotech with higher recent returns but also comes with higher volatility.

Investors should carefully consider their investment goals and risk profiles before making a decision. It is essential to evaluate the funds' expense structures, historical volatility, and performance metrics to make an informed investment choice.